Shares of Phreesia, Inc. (NYSE:PHR - Get Free Report) have been assigned an average rating of "Hold" from the nineteen brokerages that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and eight have given a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $14.00.
A number of research analysts recently weighed in on PHR shares. Canaccord Genuity Group reissued a "buy" rating and issued a $16.00 price objective on shares of Phreesia in a research note on Thursday, September 3rd. Weiss Ratings raised Phreesia from a "sell (d)" rating to a "sell (d+)" rating in a research report on Monday, October 19th. Citigroup reiterated a "market perform" rating on shares of Phreesia in a report on Tuesday, October 20th. Royal Bank Of Canada reiterated an "outperform" rating and set a $19.00 price target on shares of Phreesia in a report on Thursday, September 3rd. Finally, DA Davidson lifted their price target on shares of Phreesia from $13.00 to $15.00 and gave the company a "buy" rating in a research report on Thursday.
Read Our Latest Report on PHR
Insider Transactions at Phreesia
In other news, General Counsel Allison C. Hoffman sold 6,662 shares of Phreesia stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $10.08, for a total value of $67,152.96. Following the transaction, the general counsel directly owned 266,574 shares in the company, valued at approximately $2,687,065.92. The trade was a 2.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 5.20% of the stock is owned by company insiders.
Institutional Trading of Phreesia
Several hedge funds have recently added to or reduced their stakes in PHR. Pale Fire Capital SE bought a new position in Phreesia in the 1st quarter worth approximately $72,481,000. BlackRock Inc. bought a new position in shares of Phreesia during the 2nd quarter worth about $72,234,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Phreesia during the 2nd quarter worth about $6,274,000. Bank of America Corp DE acquired a new position in shares of Phreesia during the second quarter valued at about $6,066,000. Finally, Ieq Capital LLC acquired a new position in shares of Phreesia during the second quarter valued at about $3,689,000. Institutional investors own 92.10% of the company's stock.
Phreesia Stock Down 3.9%
PHR stock opened at $11.41 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.33. Phreesia has a 1 year low of $7.77 and a 1 year high of $21.24. The company has a fifty day simple moving average of $11.42 and a 200 day simple moving average of $10.79. The firm has a market cap of $708.22 million, a PE ratio of 67.12 and a beta of 0.75.
Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by ($0.06). Phreesia had a return on equity of 5.22% and a net margin of 2.06%. The business had revenue of $129.46 million during the quarter, compared to the consensus estimate of $129.06 million. During the same quarter in the prior year, the company posted $0.01 earnings per share. The company's revenue for the quarter was up 10.4% on a year-over-year basis. Sell-side analysts anticipate that Phreesia will post 0.33 EPS for the current fiscal year.
Phreesia Company Profile
(
Get Free Report)
Phreesia, Inc. provides software and services that help healthcare organizations manage interactions with patients. Its platform supports tasks such as patient registration and intake, appointment scheduling, payments, and communications before and after visits. Phreesia's tools include digital and mobile options for completing forms and sharing information, as well as services designed to help providers engage patients and streamline administrative workflows. The company serves healthcare providers and organizations primarily in the United States.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Phreesia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.
While Phreesia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.